SAINT PAUL, Minn., Aug. 29, 2013 -- /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2013.
Third Quarter Highlights:
Robust third quarter revenue of $7.9 million, a 15% increase over the fiscal 2012 third quarter. Sequential quarterly revenue growth of 4.8% from the fiscal 2013 second quarter
Help employers find you! Check out all the jobs and post your resume.
